April 12, 2025
Regeneron Pharmaceuticals Receives Dupixent Approval in Japan ~1 min.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has recently received approval for its drug Dupixent in Japan....
March 16, 2025
JIM CRAMER ENCOURAGES INVESTORS TO OWN REGENERON PHARMACEUTICALS INC. ~2 min.
In the latest episode of Mad Money, renowned financial expert Jim Cramer expressed his bullish stance on Regeneron Pharmaceuticals Inc. (REGN)....
March 15, 2025
Regeneron Pharmaceuticals Inc.: A Promising Investment Opportunity ~2 min.
Regeneron Pharmaceuticals Inc....
March 01, 2025
Regeneron Pharmaceuticals Inc. Reports Promising Results, Garnering Attention from Investors ~2 min.
Regeneron Pharmaceuticals Inc. (REGN) has recently announced positive results from its latest clinical trials, causing a surge in investor interest....
February 26, 2025
Regeneron Pharmaceuticals Faces Legal Pressure and Growth Potential, According to Analysts ~2 min.
Regeneron Pharmaceuticals, Inc. (REGN) is currently facing mounting pressure on both its sales and legal fronts....
February 13, 2025
Analyst Cuts Regeneron Pharmaceuticals REGN Price Target After Sales Concerns and Investor Lawsuit Hagens Berman ~2 min.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) faced a setback as an industry analyst recently cut the company's price target....
February 10, 2025
Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance ~1 min.
Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....
February 09, 2025
Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024 ~2 min.
Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....
February 07, 2025
Regeneron Pharmaceuticals Sees Positive Outlook, Analysts Say ~1 min.
Regeneron Pharmaceuticals, Inc. (REGN) is receiving positive feedback from analysts, who are bullish on the company's future prospects....
February 06, 2025
Regeneron Pharmaceuticals Inc. faces legal action for Securities Law Violations - Seek advice from The Gross Law Firm ~2 min.
Regeneron Pharmaceuticals Inc., a leading biotechnology company, is currently facing a lawsuit for alleged violations of securities laws....
